Future Perspective on Pharmacogenomics of Severe Hypoglycemia Associated with Sulfonylureas: Reply from the Authors

Ryosuke Satoa Department of Endocrinology & Metabolism, Division of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Japan and Department of Endocrinology & Metabolism, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.Correspondence[email protected]

Hiroshi Watanabeb Department of Clinical Pharmacology & Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan

Rieko Genmac Department of Endocrinology & Metabolism, Seirei Hamamatsu General Hospital, Hamamatsu, Japan

Masahiro Takeuchid Reseach Center for Clinical Pharmacology, Kitasato University, Tokyo, Japan

Masato Maekawae Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan

Hirotoshi Nakamuraf Department of Endocrinology & Metabolism, Division of Internal Medicine II, Hamamatsu University School of Medicine, Hamamatsu, Japan

References

Holstein JD , KovacsP, PatzerO, StumvollM, HolsteinA. The Ser1369Ala variant of ABCC8 and the risk for severe sulfonylurea-induced hypoglycemia in German patients with Type 2 diabetes. Pharmacogenomics13(1) , 5–7 (2012).
PubMed Web of Science ®Google Scholar
Sato R , WatanabeH, GenmaR et al. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. Pharmacogenomics11(12) , 1743–1750 (2010).
PubMed Web of Science ®Google Scholar
Chia CW , EganJM. Incretin-based therapies in Type 2 diabetes mellitus. J. Clin. Endocrinol. Metab.93(10) , 3703–3716 (2008).
PubMed Web of Science ®Google Scholar
Seino S , ZhangCL, ShibasakiT. Sulfonylurea action re-revisited. J. Diabetes Invest.1(1–2) , 37–39 (2010).
PubMed Web of Science ®Google Scholar
Zhang CL , KatohM, ShibasakiT et al. The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325(5940) , 607–610 (2009).
PubMed Web of Science ®Google Scholar
Travers ME , McCarthyMI. Type 2 diabetes and obesity: genomics and the clinic. Hum. Genet.130(1) , 41–58 (2011).
PubMed Web of Science ®Google Scholar

▪ Website

The Ministry of Health, Labour, and Welfare in Japan. Pharmaceuticals and Medical devices safety information. No. 275, December 2010 (In Japanese). www1.mhlw.go.jp/kinkyu/iyaku_j/iyaku_j/anzenseijyouhou/275.pdf
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Future Perspective on Pharmacogenomics of Severe Hypoglycemia Associated with Sulfonylureas: Reply from the Authors

References

▪ Website

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Future Perspective on Pharmacogenomics of Severe Hypoglycemia Associated with Sulfonylureas: Reply from the Authors

References

▪ Website

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date